LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE)
Report
- Report Number
- 2024601-2012-00959
- Event Type
- Malfunction
- Date Received
- October 1, 2012
- Date of Event
- August 30, 2012
- Report Date
- September 4, 2012
- Manufacturer
- ALLERGAN
- Product Code
- LTI
- PMA / PMN Number
- P000008
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER
Narratives
TAPER UNKNOWN. MEDWATCH SENT TO FDA ON: 10/01/2012. THE ACCESS PORT CONNECTOR ASSOCIATED WITH THIS REPORT HAS NOT BEEN RETURNED AND WAS DISCARDED AFTER SURGERY BY THE REPORTER. THE REPORTER OF THE COMPLAINT WAS ASKED TO INDICATE THE PRODUCT SERIAL NUMBER AND THE MODEL NUMBER. THE INFORMATION HAS NOT YET BEEN RECEIVED BY ALLERGAN. BASED UPON THE IMPLANT DATE PROVIDED BY THE REPORTER THE CONNECTOR TYPE IS EITHER A TAPER II OR A RAPIDPORT EZ TRAIN RELIEF. THE CONNECTOR TYPE CANNOT BE IDENTIFIED NOR AN ASSUMPTION BE MADE AS TO THE TYPE OF CONNECTOR ASSOCIATED WITH THIS COMPLAINT BECAUSE NO SERIAL NUMBER WAS GIVEN. ALLERGAN WILL NOT RECEIVE THE PRODUCT. THEREFORE NO ANALYSIS OR TESTING CAN BE DONE. NO ADDITIONAL INFORMATION HAS BEEN REPORTED TO ALLERGAN REGARDING THE SERIAL NUMBER OR MODEL NUMBER, EVENT DATE, IMPLANT DATE, DIAGNOSTIC TESTING, PATIENT WEIGHT OR HISTORY. DEVICE LABELING ADDRESSES THE POSSIBLE OUTCOME OF LEAKAGE AS FOLLOWS: "DEFLATION OF THE BAND MAY OCCUR DUE TO LEAKAGE FROM THE BAND, THE PORT OR THE CONNECTOR TUBING."
HEALTH PROFESSIONAL AT HOSPITAL REPORTED TO ALLERGAN REPRESENTATIVE A PORT REPLACEMENT WAS PERFORMED FOR AN ALLEGED LEAK. INVESTIGATION IN PROGRESS. FOLLOW-UP FINDINGS: PORT WAS EXPLANTED DUE TO A SUSPECTED LEAK OR TUBE DISCONNECTION. NO SERIAL NUMBER OR MODEL NUMBER WAS PROVIDED TO ALLERGAN. THE DEVICE WILL NOT BE RETURNED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE) | LTI | ALLERGAN | NA | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 33 YR |